ODDO BHF Initiates the Coverage of Aelis Farma With a “Buy” Recommendation

ODDO BHF Initiates the Coverage of Aelis Farma With a “Buy” Recommendation

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 – ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the « Company »), announces today the publication of an initiation report by ODDO BHF, one of Europe’s leading independent financial services companies specialising in research, execution and advisory. In the initiation report, published on April 7, 2022, ODDO BHF initiates the coverage of the stock with a buy recommendation and values the company at 25 euros per share. *** Next financial event: Annual General Meeting: June 28, 2022 About ODDO BHF ODDO BHF is an independent Franco-German financial services group, with a history stretching back over 170 years. It was created from the alliance of a French family-owned business built up by five generations of stockbrokers and a German bank specialising in Mittelstand companies. With 2,500 employees (1,300 in Germany and Switzerland and 1,200 in France and Tunisia), and more than 125 billion euros in assets under management, ODDO BHF operates in three main businesses, based on significant investment in market expertise: private banking, asset management and corporate and investment banking. The Group has a specific ownership structure as 65% of its capital is held by the Oddo family and 25 % by employees. This “partnership” ethos guarantees the long-term involvement of its teams. In 2020, ODDO BHF generated net banking income of 624 million euros, and at 31 December 2020, the Group had over 940 million euros of shareholders’ equity. For more information: http://www.oddo-bhf.com About AELIS FARMA Founded in 2013, Aelis Farma is a biopharmaceutical company that is developing a new class of drugs, the Signaling Specific inhibitors of the CB1 receptor of the endocannabinoid system (CB1-SSi). These new molecules hold great potential in the treatment of many brain diseases. CB1-SSi were developed…

Excerpt only …
Source : ODDO BHF Initiates the Coverage of Aelis Farma With a “Buy” Recommendation

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.